Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Therapeutic Plenary Session 1102

Atypical Parkinsonism: Challenges and Opportunities in the Coming Decade

Thursday, September 15, 2022
11:00 – 13:00

 

In this session, the faculty will discuss the current knowledge on the latest, state-of-the-art options in the diagnosis and management of atypical parkinsonism versus Parkinson’s disease at an early stage of the disease. 


Chairs:
Pietro Cortelli, Italy
Huw Morris, United Kingdom

Distinguishing Early Stage Atypical Parkinsonism from Parkinson’s Disease
Daniela Berg, Germany

Multiple System Atrophy: Biomarkers and Management Strategies
Iva Stankovic, Serbia

Tauopathies: Biomarkers and Management Strategies
Rodolfo Savica, USA

CSPC Liaisons:
Pietro Cortelli, Italy
Huw Morris, United Kingdom

At the conclusion of this session, participants should be better able to:

  1. Differentiate atypical Parkinsonism from Parkinson’s disease at an early stage
  2. Discuss biomarkers in MSA and management options
  3. Discuss biomarkers is PSP and CBD, and management options

Recommended Audience:
Clinician/General Neurology, Researcher/Basis Science, Health Professional (non-physician), Fellow/Resident/Student, Industry

Education Level:
Beginner/Foundational, Intermediate/Experienced, Advanced/Expert

 

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice